CYP7A1 and hyperlipidemia: In addition, proprotein convertase subtilisin/kexin type 9 (Pcsk9) and cholesterol 7α-hydroxylase (Cyp7a1) were the key genes both enriched in the cholesterol metabolism pathways in hyperlipidemia rats treated with HTJZD.